Novel Antimicrobials: Firms Urged To Draw Up Access & Stewardship Plans For Lower-Income Countries

Pharma firms have a set of tools and strategies at their disposal to ensure access to new antimicrobials while safeguarding their effectiveness, but companies developing some of the most promising drug candidates are not making the most of these tools, according to a new report.